Fate Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $122.0M | $440.7M | $36.1M |
| FY2025 | $111.8M | $318.9M | $46.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $122.0M | $440.7M | $36.1M |
| FY2025 | $111.8M | $318.9M | $46.6M |